KINNATE BIOPHARMA INC (KNTE) Stock Analyst Earnings Estimates
NASDAQ:KNTE - Nasdaq - US49705R1059 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A -100.00% | N/A | N/A 387.44% | N/A 77.60% | N/A 40.05% | |||||||
| EBITDA YoY % growth | N/A | N/A | -35.92M | -89.99M -150.53% | -117.92M -31.04% | -118.209M -0.25% | N/A 39.88% | N/A -5.97% | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -7.63M | -12.01M -57.40% | -36M -199.75% | -90.11M -150.31% | -118.52M -31.53% | -119.008M -0.41% | N/A 42.94% | N/A 0.27% | N/A -20.16% | N/A -17.40% | N/A 64.09% | N/A 158.11% | N/A 259.97% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -2.06 -27.42% | -2.65 -28.64% | -2.42 8.68% | N/A 47.95% | N/A 34.62% | N/A -59.75% | N/A 39.53% | N/A | N/A | N/A |
All data in USD
| Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.37 49.35% | -0.35 48.25% | -0.33 48.61% | -0.28 22.56% | -0.33 11.72% | -0.33 7.25% | -0.30 11.45% | -0.30 -7.93% |
| Revenue Q2Q % growth | N/A | N/A | N/A | N/A | ||||
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -18.474M 46.68% | -17.591M 48.47% | -16.391M 47.33% | -14.28M 25.25% | -20.196M -9.32% | -20.196M -14.81% | -20.196M -23.21% | -20.196M -41.43% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2023 Q2Q % growth | -0.36 50.00% | -0.43 | 0.07 | 16.96% |
| Q3 2023 Q2Q % growth | -0.65 7.14% | -0.69 | 0.04 | 5.59% |
| Q2 2023 Q2Q % growth | -0.68 -9.68% | -0.77 | 0.08 | 11.11% |
| Q1 2023 Q2Q % growth | -0.73 -19.67% | -0.74 | 0.01 | 1.96% |
| Q4 2022 Q2Q % growth | -0.72 -20.00% | -0.73 | 0.01 | 1.37% |
| Q3 2022 Q2Q % growth | -0.70 -22.81% | -0.62 | -0.08 | -12.97% |
| Q2 2022 Q2Q % growth | -0.62 -26.53% | -0.65 | 0.03 | 4.84% |
| Q1 2022 Q2Q % growth | -0.61 -52.50% | -0.62 | 0.01 | 1.50% |
| Q4 2021 Q2Q % growth | -0.60 -87.50% | -0.60 | 0.00 | -0.19% |
| Q3 2021 Q2Q % growth | -0.57 -43.29% | -0.55 | -0.02 | -3.49% |
| Q2 2021 Q2Q % growth | -0.49 | -0.44 | -0.05 | -11.72% |
| Q1 2021 Q2Q % growth | -0.40 | -0.37 | -0.03 | -8.18% |
| Q4 2020 Q2Q % growth | -0.32 | -0.38 | 0.06 | 15.78% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 1.14% | 5.3% | 0% | 9.55% |
| Revenue | N/A | N/A | N/A | N/A |